Immune stimulating activity of two new chitosan containing adjuvant formulations.
about
Current applications and future prospects of nanomaterials in tumor therapyOral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge.Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence.Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.Phenotype and polarization of autologous T cells by biomaterial-treated dendritic cellsIntranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.The development of contraceptive vaccines.Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in miceCurrent advances in antifertility vaccines for fertility control and noncontraceptive applications.Modulatory effects of chitosan adipate on the T and B lymphocyte subsets in mice.Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.Nanoparticles as carriers for nasal vaccine delivery.Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external regionImmunostimulatory colloidal delivery systems for cancer vaccines.Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccineNanomaterials in the application of tumor vaccines: advantages and disadvantages.Differential functional effects of biomaterials on dendritic cell maturation.Controlling chitosan-based encapsulation for protein and vaccine delivery.Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.Inhibitory effect of dibutyryl chitin ester on nitric oxide and prostaglandin E₂ production in LPS-stimulated RAW 264.7 cells.Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration.Anti-cancer efficacy of biotinylated chitosan nanoparticles in liver cancer.Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment.Effects of chitosan on growth performance and energy and protein utilisation in broiler chickens.Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment.Chitosan oligosaccharide ameliorates acute lung injury induced by blast injury through the DDAH1/ADMA pathway.Treatment with chitin microparticles is protective against lung histopathology in a murine asthma model.Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform.Stimuli-Responsive Polymers as Adjuvants and Carriers for Antigen DeliveryAntioxidant Polymers: Metal Chelating AgentsComparison of chitosan nanoparticles and chitosan hydrogels for vaccine deliveryNovel temperature and pH dual-sensitive PNIPAM/CMCS/MWCNT semi-IPN nanohybrid hydrogels: Synthesis, characterization, and DOX drug release
P2860
Q29248618-E860E78B-787C-4000-ADFB-632735051179Q33619912-BC3F7D6D-3D1D-4D6E-94AD-E5AE143E3E22Q34016706-37A0AD4F-37B6-4F76-8DB8-2300C9FBB199Q34099129-69CF0959-E864-49C8-AA7B-B2452091199BQ34161138-267C0541-FA6D-4FE3-8EF0-114216F97AEFQ34309830-E84A2F00-6961-461F-BBA7-E721D5966EEEQ34841729-1EFD6AAD-1580-4363-A38A-77D231B98127Q35091726-D27F4159-BC1D-468D-97AB-0E2B4AC587F2Q35193494-3B316396-9FFD-4BE6-81D8-5C6ED636AC55Q35622341-8992195D-65D6-475F-B33F-E6E2BE1F4180Q35628183-480078E7-6A4F-4E19-9359-61DAAE6B656CQ35839060-6FAB9DF5-F840-4BB6-A454-737B526900B9Q36124952-3AB56FD4-26C4-4AF0-AD7C-46D428BF4205Q36372534-B41B21F1-1F86-436A-A452-FB661EDF6E84Q36460849-78F085B8-FA88-4459-BB6C-BE936162B66EQ36702887-CB56394E-7F3E-4191-A563-59F1F1DFAAFDQ36925868-497AF8B0-FE81-41C0-807C-32407F572D88Q37675430-296096CF-E71D-45C1-A326-6609EC76C1F5Q37684382-B8BA63F2-E4F7-4121-B33B-DE38E5A11102Q37719553-B89B4794-C1B5-46AA-8C50-0D0CB0B9F52BQ39302191-05086421-762A-4AD6-AD77-AED5D9E0040DQ41244310-3AB7F41B-0FD0-4E7A-A9C5-F1241D88292BQ41709085-1A32FC83-5B79-45FC-BBB7-334FFC0D36E2Q46026100-7B20F03A-419A-4405-B532-ABEE76FAE590Q46789209-ECF70DEF-3A9B-4F1F-B3B8-CADD84084945Q47682175-80C82F56-2C3B-4C6B-81E2-86894DFE4524Q50055389-A36F50AE-9754-4814-AB21-D1713CA5FFAEQ51164502-02C10683-1403-4EE1-9959-B06922F64987Q54474177-C404D793-8CBB-4B84-BC11-89CA7F8AFCB1Q57340495-9A585096-F6EA-46AA-BCA7-D16C3FEDD70CQ57341888-474E75B5-5A1B-4844-ABA4-77B3E4893EAFQ57349484-CE3B5D66-7B8D-448B-B2FB-D0018F92718DQ57369193-0C64B166-5CEF-43BF-BA3A-97FFF8DD4274
P2860
Immune stimulating activity of two new chitosan containing adjuvant formulations.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Immune stimulating activity of two new chitosan containing adjuvant formulations.
@en
Immune stimulating activity of two new chitosan containing adjuvant formulations.
@nl
type
label
Immune stimulating activity of two new chitosan containing adjuvant formulations.
@en
Immune stimulating activity of two new chitosan containing adjuvant formulations.
@nl
prefLabel
Immune stimulating activity of two new chitosan containing adjuvant formulations.
@en
Immune stimulating activity of two new chitosan containing adjuvant formulations.
@nl
P1433
P1476
Immune stimulating activity of two new chitosan containing adjuvant formulations.
@en
P2093
Martinez ML
Seferian PG
P304
P356
10.1016/S0264-410X(00)00248-6
P407
P577
2000-11-01T00:00:00Z